Normovidona (Povidone, Iodinated)

Povidone‑iodine releases free iodine when applied. The iodine penetrates the cell walls of microorganisms and inactivates essential proteins and nucleic acids, causing rapid cell death. This mechanism provides broad‑spectrum activity against bacteria, viruses, fungi and protozoa.

The amount of Normovidona applied is determined by the prescribing clinician based on the size of the area to be treated and the intended use. Typically, a thin layer is spread over the skin or wound and allowed to dry, but exact dosing should follow the healthcare professional’s instructions.

Safety data for povidone‑iodine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies any possible risk, and the decision should be made by a qualified healthcare provider.

To order Normovidona, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both povidone‑iodine and chlorhexidine are broad‑spectrum topical antiseptics, but they differ in spectrum, onset of action and residue. Povidone‑iodine releases iodine rapidly and is effective against a wider range of organisms, including viruses, whereas chlorhexidine has a longer residual effect on skin but less activity against certain spores and viruses.

Normovidona should be stored at ambient temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct sunlight, and avoid exposure to moisture. Do not freeze the product, and keep it out of reach of children.

Normovidona is applied topically to the skin or wound. Clean the area gently, then apply a thin, even layer of the solution or gel using a sterile gauze or applicator. Allow it to air‑dry; re‑application may be performed as directed by a healthcare professional.

Serious risks include allergic contact dermatitis, which can present as severe rash, swelling or blistering, and systemic iodine toxicity that may affect thyroid function, especially in patients with pre‑existing thyroid disease. Rarely, anaphylaxis can occur and requires immediate medical attention.

Normovidona should be avoided in individuals with known iodine allergy, those with active thyroid disease who are not under medical supervision, infants younger than two months, and patients who are pregnant or breastfeeding unless a clinician determines that the benefit outweighs potential risks.